What are the classifications of myocardial infarction, including STEMI, NSTEMI, and the universal definition types 1 through 5?

Myocardial Infarction Classification

Myocardial infarction is classified into five distinct types based on the Universal Definition, with the primary clinical distinction being between STEMI (ST-elevation MI) and NSTEMI (non-ST-elevation MI) for immediate treatment decisions, particularly regarding reperfusion therapy. 1

Universal Classification System (Types 1-5)

The Universal Definition provides a mechanistic classification framework 1:

Type 1 MI: Spontaneous Atherothrombotic MI

• Caused by atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection
• Results in intraluminal thrombus formation in coronary arteries
• Leads to decreased myocardial blood flow or distal platelet emboli
• Represents the majority of MI cases (65-90% of all MIs, 72% in prospective studies) 2, 3
• Can present as either STEMI (57.1%) or NSTEMI (42.9%) 4

Type 2 MI: Supply-Demand Mismatch

• Myocardial injury from oxygen supply-demand imbalance unrelated to acute coronary atherothrombosis
• Common precipitating factors include:
  • Tachyarrhythmias or bradyarrhythmias
  • Coronary artery spasm
  • Coronary embolism
  • Anemia
  • Respiratory failure
  • Hypotension or severe hypertension
  • Coronary endothelial dysfunction 1
• Comprises approximately 26% of all MI cases 3
• More commonly presents as NSTEMI (81.2%) than STEMI (18.8%) 4
• Critical distinction: 45% of Type 2 MI patients have no significant coronary artery disease 3

Type 3 MI: Sudden Cardiac Death

• Cardiac death with symptoms suggesting myocardial ischemia
• Presumed new ischemic ECG changes or new left bundle branch block
• Death occurs before biomarkers can be obtained or rise
• Rare cases where biomarkers were not collected 1

Type 4a MI: PCI-Related

• Procedure-related myocardial infarction associated with percutaneous coronary intervention 1

Type 4b MI: Stent Thrombosis-Related

• MI associated with documented stent thrombosis 1

Type 5 MI: CABG-Related

• Procedure-related myocardial infarction associated with coronary artery bypass grafting 1

Clinical Classification: STEMI vs NSTEMI

For immediate treatment decisions, the STEMI/NSTEMI distinction takes precedence:

STEMI (ST-Elevation MI)

• ST elevation in two contiguous ECG leads
• Requires immediate reperfusion therapy
• Can be either Type 1 or Type 2 MI mechanistically 1

NSTEMI (Non-ST-Elevation MI)

• No ST elevation at presentation
• Elevated cardiac biomarkers (troponin above 99th percentile)
• Most common presentation for both Type 1 and Type 2 MI 2
• Important caveat: A substantial proportion of NSTEMI patients have complete coronary occlusion and may benefit from urgent intervention 5

Critical Clinical Distinctions

Type 1 vs Type 2 MI: Why It Matters

Distinguishing between Type 1 and Type 2 MI early in the clinical course is essential because management strategies differ fundamentally 2:

Type 1 MI patients:

• Undergo coronary angiography in 77.7% of cases
• Receive PCI in 79.2% of cases (range 44-93%)
• Benefit from antiplatelet therapy and revascularization 2

Type 2 MI patients:

• Undergo coronary angiography in only 31.5% of cases
• Receive PCI in 40.2% of cases (range 0-87.5%)
• Are older with more comorbidities
• Have 2.75 times higher long-term mortality (HR 2.75, p<0.001) 6
• Require treatment focused on the underlying precipitant (e.g., treating anemia, controlling arrhythmias, managing respiratory failure) 2
• In-hospital mortality causes are often non-cardiovascular 2

Common Pitfalls

1. Misclassification is common: Studies show wide variation in Type 1 vs Type 2 classification, with inconsistent inclusion of STEMI patients and variable use of coronary angiography 7

2. Risk score limitations: Traditional risk scores (GRACE, CRUSADE) perform differently between Type 1 and Type 2 MI, potentially leading to inappropriate risk stratification 6

3. Delayed recognition of occlusion: In one study, 46.1% of patients had coronary occlusion without ST elevation (STEMI-negative OMI), experiencing median door-to-angiography times of 540 minutes versus 39 minutes for STEMI-positive patients 5

4. Biomarker interpretation: Elevated troponin alone does not distinguish MI type—clinical context and precipitating factors must guide classification 1

Diagnostic Approach

When evaluating elevated troponin:

1. Confirm MI criteria: Rising and/or falling pattern of cardiac biomarkers (troponin above 99th percentile) plus evidence of myocardial ischemia 1

2. Obtain immediate ECG: Determine STEMI vs NSTEMI for reperfusion decisions

3. Identify mechanism:

   • Look for acute coronary syndrome features (Type 1)
   • Search for supply-demand mismatch precipitants (Type 2)
   • Consider procedure-related causes (Types 4-5)

4. Consider angiography timing: Type 1 MI warrants urgent/emergent angiography; Type 2 MI requires treating the underlying precipitant first 2

The inter-physician reliability for Universal Classification is very good (weighted kappa=0.84) and performs better than STEMI/NSTEMI classification alone (weighted kappa=0.78) 4, supporting its clinical utility when applied systematically.